Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway

Scandinavian Journal of Public Health

Volumn 38, Issue 3, 2010, Pages 275-282

  Harstad, Ingunn ^a   Jacobsen, Geir W ^a   Heldal, Einar ^b   Winje, Brita A ^b   Steinshamn, Sigurd L ^a   Garåsen, Helge ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Immigrant; immigration; refugee; screening; tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; COHORT ANALYSIS; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; LATENT TUBERCULOSIS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MIGRATION; NORWAY; REFUGEE; REGISTER; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; COHORT STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MASS CHEST X-RAY; MASS SCREENING; MIDDLE AGED; NORWAY; REFUGEES; REGISTRIES; TUBERCULIN TEST; YOUNG ADULT;

EID: 77951933532     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/1403494809353823     Document Type: Article

References (17)

1. Winje B.A., Mannsåker T., Heldal E., Dahle U.R. Tuberkulose i Norge 2006 (Tuberculosis in Norway, 2006. A report from the Infectious Disease Control Register) (Norwegian). MSISrapport 2007;35.
2. Dahle U.R., Sandven P., Heldal E., Caugant D.A. Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2003;41(7):2968-2973.
3. Farah M.G., Tverdal A., Selmer R., Heldal E., Bjune G. Tuberculosis in Norway by country of birth, 1986-1999. Int J Tuberc Lung Dis 2003;7(3):232-5.
4. WHO Global Health atlas [database on the Internet] 2009. http://apps.who.int/globalatlas/dataQuery/reportData.asp?rptType=1 (accessed 17 August 2009).
5. Johnsen N.L., Steen T.W., Meyer H.E., Heldal E., Skarpaas I.J.K., Bjune G. Cohort analysis of asylum seekers in Oslo, Norway, 1987-1995: effectiveness of screening at entry and TB incidence in subsequent years. Int J Tuberc Lung Dis 2005; 9(1):37-42.
6. Broekmans J.F., Migliori G.B., Rieder H.L., Lees J., Ruutu P., Loddenkemper R., et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur Respir J 2002;19:765-775.
7. Forskrift om tuberkulosekontroll (Norwegian)[Regulations on control of tuberculosis] In: Services MoHaC, editor; 2002. (http://www.lovdata.no/cgi-wift/ldles?doc=/sf/sf/sf-20020621-0567.html) (accessed 26 October 2009).
8. Nasjonalt Folkehelseinstitutt. Forebygging og kontroll av tuberkulose, en veileder (Norwegian)[Guidelines for prevention and control of tuberculosis], 7th edn. Oslo: Nasjonalt Folkehelseinstitutt; 2002.
9. Harstad I., Heldal E., Steinshamn S.L., Garasen H., Jacobsen G.W. Tuberculosis screening and follow-up of asylum seekers in Norway. A cohort study. BMC Public Health 2009;9(1):141.
10. Winje B.A., Oftung F., Korsvold G.O., Mannsåker T., Jeppesen A.S., Harstad I., et al. Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERON TB Gold with tuberculin skin test. BMC Infectious Diseases [serial on the Internet]. 2008;8:65.
11. Breuss E., Helbling P., Altpeter E., Zellweger J.-P. Screening and treatment for latent tuberculosis infection among asylum seekers entering Switzerland. Swiss Med Wkly 2002;132:197-200.
12. von Reyn CF, Horsburgh C.R., Olivier K.N., Barnes P.F., Waddell R., Warren C., et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001;5(12):1122-8.
13. Kang Y.A., Lee H.W., Yoon H.I., Cho B., Han S.K., Shim Y.S., et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293(22):2756-2761.
14. Prophylaxis IUATCo. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982;60(4):555-564.
15. Van Burg JL, Verver S., Borgdorff M.W. The epidemiology of tuberculosis among asylum seekers in the Netherlands: implication for screening. Int J Tuberc Lung Dis 2003;7(2):139-144.
16. Yew W.W., Leung C.C. Antituberculosis drugs and hepatotoxicity. Respirology 2006;11(6):699-707.
17. Richards B., Kozak R., Brassard P., Menzies D., Schwartzman K. Tuberculosis surveillance among new immigrants in Montreal. Int J Tuberc Lung Dis 2005;9(8):858-864.